Safety Study Day 71 [clinicaltrials_resource:87e7d0ee145e7c1de816b8fbb7becb6f]
The safety and tolerability of a single dose SC injection of CAT-354 in healthy male and/or female Japanese subjects will be assessed through the incidence of adverse events (AEs), and the assessment of vital signs, physical examinations, laboratory parameters, and electrocardiograms.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Safety Study Day 71 [clinicaltrials_resource:87e7d0ee145e7c1de816b8fbb7becb6f]
The safety and tolerability of a single dose SC injection of CAT-354 in healthy male and/or female Japanese subjects will be assessed through the incidence of adverse events (AEs), and the assessment of vital signs, physical examinations, laboratory parameters, and electrocardiograms.
Bio2RDF identifier
87e7d0ee145e7c1de816b8fbb7becb6f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:87e7d0ee145e7c1de816b8fbb7becb6f
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
Study Day 71
description
The safety and tolerability of ...... eters, and electrocardiograms.
identifier
clinicaltrials_resource:87e7d0ee145e7c1de816b8fbb7becb6f
title
Safety Study Day 71
@en
type
label
Safety Study Day 71 [clinicaltrials_resource:87e7d0ee145e7c1de816b8fbb7becb6f]
@en